235 related articles for article (PubMed ID: 33261044)
1. Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver.
Igreja Sá IC; Tripska K; Hroch M; Hyspler R; Ticha A; Lastuvkova H; Schreiberova J; Dolezelova E; Eissazadeh S; Vitverova B; Najmanova I; Vasinova M; Pericacho M; Micuda S; Nachtigal P
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261044
[TBL] [Abstract][Full Text] [Related]
2. High soluble endoglin levels regulate cholesterol homeostasis and bile acids turnover in the liver of transgenic mice.
Dolezelova E; Sa ICI; Prasnicka A; Hroch M; Hyspler R; Ticha A; Lastuvkova H; Cermanova J; Pericacho M; Visek J; Lasticova M; Micuda S; Nachtigal P
Life Sci; 2019 Sep; 232():116643. PubMed ID: 31299237
[TBL] [Abstract][Full Text] [Related]
3. Long term effects of soluble endoglin and mild hypercholesterolemia in mice hearts.
Vitverova B; Najmanova I; Vicen M; Tripska K; Sa ICI; Hyspler R; Pericacho M; Nachtigal P
PLoS One; 2020; 15(5):e0233725. PubMed ID: 32470058
[TBL] [Abstract][Full Text] [Related]
4. High Levels of Soluble Endoglin Induce a Proinflammatory and Oxidative-Stress Phenotype Associated with Preserved NO-Dependent Vasodilatation in Aortas from Mice Fed a High-Fat Diet.
Jezkova K; Rathouska J; Nemeckova I; Fikrova P; Dolezelova E; Varejckova M; Vitverova B; Tysonova K; Serwadczak A; Buczek E; Bernabeu C; Lopez-Novoa JM; Chlopicki S; Nachtigal P
J Vasc Res; 2016; 53(3-4):149-162. PubMed ID: 27721318
[TBL] [Abstract][Full Text] [Related]
5. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
[TBL] [Abstract][Full Text] [Related]
6. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
7. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH
J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987
[TBL] [Abstract][Full Text] [Related]
8. Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aorta.
Vitverova B; Blazickova K; Najmanova I; Vicen M; Hyšpler R; Dolezelova E; Nemeckova I; Tebbens JD; Bernabeu C; Pericacho M; Nachtigal P
Atherosclerosis; 2018 Apr; 271():15-25. PubMed ID: 29459262
[TBL] [Abstract][Full Text] [Related]
9. Endoglin and soluble endoglin in liver sinusoidal endothelial dysfunction in vivo.
Eissazadeh S; Mohammadi S; Faradonbeh FA; Rathouska JU; Nemeckova I; Tripska K; Vitverova B; Dohnalkova E; Vasinova M; Fikrova P; Sa ICI; Micuda S; Nachtigal P
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166990. PubMed ID: 38110128
[TBL] [Abstract][Full Text] [Related]
10. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
11. Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis.
Suga T; Yamaguchi H; Ogura J; Shoji S; Maekawa M; Mano N
Toxicol Appl Pharmacol; 2019 Sep; 379():114664. PubMed ID: 31306673
[TBL] [Abstract][Full Text] [Related]
12. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
Elife; 2023 Jan; 12():. PubMed ID: 36648330
[TBL] [Abstract][Full Text] [Related]
13. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
[TBL] [Abstract][Full Text] [Related]
14. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis.
Lastuvkova H; Faradonbeh FA; Schreiberova J; Hroch M; Mokry J; Faistova H; Nova Z; Hyspler R; Igreja Sa IC; Nachtigal P; Stefela A; Pavek P; Micuda S
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208774
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol Induces Nrf-2- and HIF-1
Kaminsky-Kolesnikov Y; Rauchbach E; Abu-Halaka D; Hahn M; García-Ruiz C; Fernandez-Checa JC; Madar Z; Tirosh O
Oxid Med Cell Longev; 2020; 2020():5393761. PubMed ID: 32566088
[TBL] [Abstract][Full Text] [Related]
17. High soluble endoglin levels do not induce changes in structural parameters of mouse heart.
Rathouska J; Fikrova P; Mrkvicova A; Blazickova K; Varejckova M; Dolezelova E; Nemeckova I; Vitverova B; Peslova L; Gallardo-Vara E; Pericacho M; Nachtigal P
Heart Vessels; 2017 Aug; 32(8):1013-1024. PubMed ID: 28382387
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
Kumar S; Verma AK; Rani R; Sharma A; Wang J; Shah SA; Behari J; Salazar Gonzalez R; Kohli R; Gandhi CR
Hepatology; 2020 Nov; 72(5):1586-1604. PubMed ID: 32031683
[TBL] [Abstract][Full Text] [Related]
19. Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model.
Ipsen DH; Skat-Rørdam J; Tsamouri MM; Latta M; Lykkesfeldt J; Tveden-Nyborg P
Mol Genet Genomics; 2019 Jun; 294(3):649-661. PubMed ID: 30759275
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
Krishnan A; Abdullah TS; Mounajjed T; Hartono S; McConico A; White T; LeBrasseur N; Lanza I; Nair S; Gores G; Charlton M
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G666-G680. PubMed ID: 28232454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
